Matthew D Wilcox
Overview
Explore the profile of Matthew D Wilcox including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Prufert F, Bonengel S, Kollner S, Griesser J, Wilcox M, Chater P, et al.
Nanomedicine (Lond)
. 2017 Sep;
12(22):2713-2724.
PMID: 28960133
Aim: Aim of the study was the development of ζ potential changing nanoparticles as gene delivery system for the cystic fibrosis transmembrane conductance regulator gene. Methods: Chitosan and carboxymethyl cellulose...
12.
Wilcox M, Del Bosque R, Parizek K, Sia J, Eigenbrodt E, McDougall M
Annu Int Conf IEEE Eng Med Biol Soc
. 2017 Mar;
2016:6258-6261.
PMID: 28269681
This work describes the construction and testing of a three-element, double-tuned receive array and transmit coils for 31P-1H spectroscopy and imaging. The receive coils were geometrically-decoupled, single-loop surface coils and...
13.
Rispoli J, Wilcox M, By S, Wright S, McDougall M
Annu Int Conf IEEE Eng Med Biol Soc
. 2017 Mar;
2016:6250-6253.
PMID: 28269680
This work investigates the efficacy of "coplanar shielding," in which copper shields are oriented concentric and coplanar to the RF coils rather than implemented as a full ground plane behind...
14.
Pearson J, Chater P, Wilcox M
Ther Deliv
. 2016 Mar;
7(4):229-44.
PMID: 27010985
The key criterion for a nanoparticle drug-delivery system is the ability to produce substantial bioavailability without damaging the physiological protective mechanisms. The main area for drug delivery is the aerodigestive...
15.
Chater P, Wilcox M, Houghton D, Pearson J
Food Funct
. 2015 Sep;
6(11):3420-7.
PMID: 26416783
Seaweeds are an underutilised nutritional resource that could not only compliment the current western diet but potentially bring additional health benefits over and above their nutritional value. There are four...
16.
Houghton D, Wilcox M, Chater P, Brownlee I, Seal C, Pearson J
Food Hydrocoll
. 2015 Jul;
49:18-24.
PMID: 26146432
Alginates are classed as a dietary fibre and have been shown to inhibit digestive enzymes , and therefore could be used as an obesity treatment. The current study aims to...
17.
Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier
Pereira de Sousa I, Cattoz B, Wilcox M, Griffiths P, Dalgliesh R, Rogers S, et al.
Eur J Pharm Biopharm
. 2015 Feb;
97(Pt A):257-64.
PMID: 25661320
The intestinal mucus gel layer represents a stumbling block for drug adsorption. This study is aimed to formulate a nanoparticulate system able to overcome this barrier by cleaving locally the...
18.
Pereira de Sousa I, Steiner C, Schmutzler M, Wilcox M, Veldhuis G, Pearson J, et al.
Eur J Pharm Biopharm
. 2015 Jan;
97(Pt A):273-9.
PMID: 25576256
The GI mucus layer represents a significant block to drug carriers absorption. Taking an example from nature, virus-mimicking nanoparticles (NPs) with highly densely charged surface were designed with the aim...
19.
Houghton D, Wilcox M, Brownlee I, Chater P, Seal C, Pearson J
Food Chem
. 2014 Jan;
151:352-7.
PMID: 24423543
To assess the efficacy of alginate as a modifier of enzyme activity, a suitable method to quantify its release must be developed. This paper develops and assesses the ability of...
20.
Friedl H, Dunnhaupt S, Hintzen F, Waldner C, Parikh S, Pearson J, et al.
J Pharm Sci
. 2013 Nov;
102(12):4406-13.
PMID: 24258284
The aim of this study was the development of a novel mucus diffusion model and the approval thereof by self-nanoemulsifying drug delivery systems (SNEDDSs). For diffusion experiments, various SNEDD formulations...